Azenta AZTA Multiomics — Total Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Azenta in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Azenta’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Azenta's multiomics — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Azenta's multiomics — total revenue?
- Azenta (AZTA) reported multiomics — total revenue of $63.7M in Q1 2026.
- How has Azenta's multiomics — total revenue changed year-over-year?
- Azenta's multiomics — total revenue increased by 0.3% year-over-year, from $63.52M to $63.7M.
- What is the long-term trend for Azenta's multiomics — total revenue?
- Over 3 years (2022 to 2025), Azenta's multiomics — total revenue has grown at a 2.4% compound annual growth rate (CAGR), from $250.94M to $269.23M.
- What does multiomics — total revenue mean?
- The total gross income generated from the sale of goods and services within the Multiomics segment, excluding applicable taxes. This metric serves as a primary indicator of market demand and the segment's ability to capture value from its genomic and multiomics service offerings. Growth in this figure reflects successful commercial execution and market penetration.